{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:07:44Z","timestamp":1774685264458,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00929-z","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T03:58:50Z","timestamp":1756267130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Insights into the interaction of Fibrinogen with Timolol Maleate and elucidation of binding sites via. spectroscopic and molecular docking study"],"prefix":"10.1038","volume":"15","author":[{"given":"Neha Govind","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu Radha","family":"Pathania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harman Deep","family":"Kour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhas","family":"Ballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhayveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Bhowmik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balewgize Amare","family":"Zeru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"929_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1749-6632.1983.tb23265.x","volume":"408","author":"DW Chung","year":"1983","unstructured":"Chung, D. W., Rixon, M. W., Que, B. G. & Davie, E. W. Cloning of fibrinogen genes and their cDNA. Ann. N. Y. Acad. Sci. 408, 449\u2013456 (1983).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"929_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1021\/ja01257a056","volume":"64","author":"EC Bingham","year":"1942","unstructured":"Bingham, E. C. & Roepke, R. R. The rheology of the blood. II. The effect of fibrinogen on the fluidity of blood plasma. J. Am. Chem. Soc. 64 (5), 1204\u20131206 (1942).","journal-title":"J. Am. Chem. Soc."},{"issue":"42","key":"929_CR3","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1039\/C6SM01895E","volume":"12","author":"A Bratek-Skicki","year":"2016","unstructured":"Bratek-Skicki, A., \u017beliszewska, P. & Ruso, J. M. Fibrinogen: a journey into biotechnology. Soft Matter. 12 (42), 8639\u20138653 (2016).","journal-title":"Soft Matter"},{"key":"929_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1749-6632.1983.tb23245.x","volume":"408","author":"C Cohen","year":"1983","unstructured":"Cohen, C. et al. The structure of fibrinogen and fibrin: I. Electron microscopy and X-ray crystallography of fibrinogen. Ann. NY Acad. Sci. 408, 194\u2013213 (1983).","journal-title":"Ann. NY Acad. Sci."},{"key":"929_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.saa.2015.06.087","volume":"151","author":"H Zhang","year":"2015","unstructured":"Zhang, H., Wu, P., Zhu, Z. & Wang, Y. Interaction of \u03b3-Fe2O3 nanoparticles with fibrinogen. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 151, 40\u201347 (2015).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"issue":"1","key":"929_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1021\/bi00116a035","volume":"31","author":"R De Cristofaro","year":"1992","unstructured":"De Cristofaro, R. & Di Cera, E. Modulation of thrombin-fibrinogen interaction by specific ion effects. Biochemistry 31 (1), 257\u2013265 (1992).","journal-title":"Biochemistry"},{"key":"929_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jcis.2013.12.025","volume":"419","author":"A Marucco","year":"2014","unstructured":"Marucco, A. et al. Hydroxyl density affects the interaction of fibrinogen with silica nanoparticles at physiological concentration. J. Colloid Interface Sci. 419, 86\u201394 (2014).","journal-title":"J. Colloid Interface Sci."},{"issue":"28","key":"929_CR8","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1016\/j.febslet.2007.10.049","volume":"581","author":"S Roy","year":"2007","unstructured":"Roy, S. & Dasgupta, A. K. Controllable self-assembly from fibrinogen\u2013gold (fibrinogen\u2013Au) and thrombin\u2013silver (thrombin\u2013Ag) nanoparticle interaction. FEBS Lett. 581 (28), 5533\u20135542 (2007).","journal-title":"FEBS Lett."},{"key":"929_CR9","doi-asserted-by":"publisher","first-page":"114667","DOI":"10.1016\/j.molliq.2020.114667","volume":"324","author":"M Gonzalez-Durruthy","year":"2021","unstructured":"Gonzalez-Durruthy, M., Rial, R., Cordeiro, M. N. D., Liu, Z. & Ruso, J. M. Exploring the conformational binding mechanism of fibrinogen induced by interactions with penicillin \u03b2-lactam antibiotic drugs. J. Mol. Liq. 324, 114667 (2021).","journal-title":"J. Mol. Liq."},{"issue":"2","key":"929_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.colsurfb.2011.06.015","volume":"87","author":"N Hassan","year":"2011","unstructured":"Hassan, N., Maldonado-Valderrama, J., Gunning, A. P., Morris, V. J. & Ruso, J. M. Investigating the effect of an arterial hypertension drug on the structural properties of plasma protein. Colloids Surf.  B. 87 (2), 489\u2013497 (2011).","journal-title":"Colloids Surf. B"},{"issue":"10","key":"929_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.recesp.2019.02.023","volume":"72","author":"E Oliver","year":"2019","unstructured":"Oliver, E., Mayor Jr, F. & D\u2019Ocon, P. Beta-blockers: historical perspective and mechanisms of action. Rev.Espa\u00f1ola De Cardiol. (Engl. Ed.) 72 (10), 853\u2013862 (2019).","journal-title":"Rev.Espa\u00f1ola De Cardiol. (Engl. Ed.)"},{"issue":"9","key":"929_CR12","doi-asserted-by":"publisher","first-page":"D2","DOI":"10.1016\/0002-9149(83)90636-7","volume":"52","author":"LH Opie","year":"1983","unstructured":"Opie, L. H. Basis for cardiovascular therapy with beta-blocking agents. Am. J. Cardiol. 52 (9), D2\u2013D9 (1983).","journal-title":"Am. J. Cardiol."},{"key":"929_CR13","doi-asserted-by":"crossref","unstructured":"Mazzo, D. J. & Loper, A. E. Timolol maleate. In Analytical Profiles of Drug Substances, Vol. 16  641\u2013692  (Academic, 1987).","DOI":"10.1016\/S0099-5428(08)60566-3"},{"issue":"9","key":"929_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.2042-7158.1989.tb06551.x","volume":"41","author":"S Karhuvaara","year":"1989","unstructured":"Karhuvaara, S., Kaila, T. & Huupponen, R. \u03b2-Adrenoceptor antagonist activities and binding affinities of timolol enantiomers in rat atria. J. Pharm. Pharmacol. 41 (9), 649\u2013650 (1989).","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"929_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1742-7843.2011.00694.x","volume":"108","author":"M Volotinen","year":"2011","unstructured":"Volotinen, M., Hakkola, J., Pelkonen, O., Vapaatalo, H. & M\u00e4enp\u00e4\u00e4, J. Metabolism of ophthalmic Timolol: new aspects of an old drug. Basic Clin. Pharmacol. Toxicol. 108 (5), 297\u2013303 (2011).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"929_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1475-097X.2002.00430.x","volume":"22","author":"J Nino","year":"2002","unstructured":"Nino, J. et al. Cardiovascular effects of ophthalmic 0.5% timolol aqueous solution and 0.1% timolol hydrogel. Clin. Physiol. Funct. Imaging 22 (4), 271\u2013278 (2002).","journal-title":"Clin. Physiol. Funct. Imaging"},{"issue":"2","key":"929_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/clpt.1985.23","volume":"37","author":"AE Sweany","year":"1985","unstructured":"Sweany, A. E., Moncloa, F., Vickers, F. F. & Zupkis, R. V. Antiarrhythmic effects of intravenous timolol in supraventricular arrhythmias. Clin. Pharmacol. Ther. 37 (2), 124\u2013127 (1985).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"929_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jfo.2018.04.012","volume":"41","author":"S Lazreg","year":"2018","unstructured":"Lazreg, S. et al. Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-na\u00efve patients and patients intolerant to other hypotensive medications. J. Fr. Ophtalmol. 41 (10), 945\u2013954 (2018).","journal-title":"J. Fr. Ophtalmol."},{"issue":"2\u20133","key":"929_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jphotochem.2006.06.015","volume":"185","author":"PB Kandagal","year":"2007","unstructured":"Kandagal, P. B., Seetharamappa, J., Shaikh, S. M. T. & Manjunatha, D. H. Binding of Trazodone hydrochloride with human serum albumin: a spectroscopic study. J. Photochem. Photobiol. A 185 (2\u20133), 239\u2013244 (2007).","journal-title":"J. Photochem. Photobiol. A"},{"issue":"12","key":"929_CR20","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.1016\/j.bmc.2008.05.002","volume":"16","author":"YL Jiang","year":"2008","unstructured":"Jiang, Y. L. Design, synthesis and spectroscopic studies of Resveratrol aliphatic acid ligands of human serum albumin. Bioorg. Med. Chem. 16 (12), 6406\u20136414 (2008).","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"929_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1211\/0022357991772079","volume":"51","author":"DE Epps","year":"1999","unstructured":"Epps, D. E., Raub, T. J., Caiolfa, V., Chiari, A. & Zamai, M. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic Tryptophan fluorescence of the protein. J. Pharm. Pharmacol. 51 (1), 41\u201348 (1999).","journal-title":"J. Pharm. Pharmacol."},{"issue":"8","key":"929_CR22","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1021\/la011681u","volume":"18","author":"P Martinez-Landeira","year":"2002","unstructured":"Martinez-Landeira, P., Ruso, J. M., Prieto, G., Sarmiento, F. & Jones, M. N. The interaction of human serum albumin with Dioctanoylphosphatidylcholine in aqueous solutions. Langmuir 18 (8), 3300\u20133305 (2002).","journal-title":"Langmuir"},{"issue":"1","key":"929_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bios.2008.03.009","volume":"24","author":"Q Zhang","year":"2008","unstructured":"Zhang, Q., Huang, Y., Zhao, R., Liu, G. & Chen, Y. Determining binding sites of drugs on human serum albumin using FIA-QCM. Biosens. Bioelectron. 24 (1), 48\u201354 (2008).","journal-title":"Biosens. Bioelectron."},{"issue":"2","key":"929_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpba.2008.11.035","volume":"49","author":"JS Mandeville","year":"2009","unstructured":"Mandeville, J. S., Froehlich, E. & Tajmir-Riahi, H. A. Study of Curcumin and genistein interactions with human serum albumin. J. Pharm. Biomed. Anal. 49 (2), 468\u2013474 (2009).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"929_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1021\/ci7003626","volume":"48","author":"S Renner","year":"2008","unstructured":"Renner, S., Derksen, S., Radestock, S. & M\u00f6rchen, F. Maximum common binding modes (MCBM): consensus Docking scoring using multiple ligand information and interaction fingerprints. J. Chem. Inf. Model. 48 (2), 319\u2013332 (2008).","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"929_CR26","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1080\/07391102.2017.1384397","volume":"36","author":"S Khatun","year":"2018","unstructured":"Khatun, S. Riyazuddeen, interaction of Colchicine with BSA: spectroscopic, calorimetric and molecular modelling approaches. J. Biomol. Struct. Dyn. 36 (12), 3122\u20133129 (2018).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"929_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jphotobiol.2008.07.008","volume":"93","author":"X Ling","year":"2008","unstructured":"Ling, X., Zhong, W., Huang, Q. & Ni, K. Spectroscopic studies on the interaction of Pazufloxacin with calf thymus DNA. J. Photochem. Photobiol., B 93 (3), 172\u2013176 (2008).","journal-title":"J. Photochem. Photobiol., B"},{"key":"929_CR28","doi-asserted-by":"publisher","first-page":"112671","DOI":"10.1016\/j.molliq.2020.112671","volume":"303","author":"F Ameen","year":"2020","unstructured":"Ameen, F. et al. A detailed insight into the interaction of memantine with bovine serum albumin: a spectroscopic and computational approach. J. Mol. Liq. 303, 112671 (2020).","journal-title":"J. Mol. Liq."},{"key":"929_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.saa.2014.10.104","volume":"138","author":"N Shahabadi","year":"2015","unstructured":"Shahabadi, N. & Amiri, S. Spectroscopic and computational studies on the interaction of DNA with Pregabalin drug. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 138, 840\u2013845 (2015).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"929_CR30","doi-asserted-by":"crossref","unstructured":"Fu, L. et al.  Mechanism evaluation of the interactions between flavonoids and bovine serum albumin basedonmulti-spectroscopy, molecular docking and Q-TOFHR-MS analyses. Food Chem.  203, 150\u2013157  (2016).","DOI":"10.1016\/j.foodchem.2016.01.105"},{"key":"929_CR31","doi-asserted-by":"publisher","first-page":"106394","DOI":"10.1016\/j.bpc.2020.106394","volume":"263","author":"V Saranya","year":"2020","unstructured":"Saranya, V., Mary, P. V., Vijayakumar, S. & Shankar, R. The hazardous effects of the environmental toxic gases on amyloid betapeptide aggregation: a theoretical perspective. Biophys. Chem. 263, 106394 (2020).","journal-title":"Biophys. Chem."},{"key":"929_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0076-6879(95)46006-3","volume":"246","author":"RW Woody","year":"1995","unstructured":"Woody, R. W. Circular dichroism. Methods Enzymol. 246, 34\u201371 (1995).","journal-title":"Methods Enzymol."},{"issue":"40","key":"929_CR33","doi-asserted-by":"publisher","first-page":"11855","DOI":"10.1021\/acs.langmuir.0c01881","volume":"36","author":"S Alamdari","year":"2020","unstructured":"Alamdari, S. et al. Orientation and conformation of proteins at the air\u2013water interface determined from integrative molecular dynamics simulations and sum frequency generation spectroscopy. Langmuir 36 (40), 11855\u201311865 (2020).","journal-title":"Langmuir"},{"issue":"11","key":"929_CR34","doi-asserted-by":"publisher","first-page":"e26186","DOI":"10.1371\/journal.pone.0026186","volume":"6","author":"E Ahmad","year":"2011","unstructured":"Ahmad, E. et al. Stereo-selectivity of human serum albumin to enantiomeric and isoelectronic pollutants dissected by spectroscopy, calorimetry and bioinformatics. Plos One 6 (11), e26186 (2011).","journal-title":"Plos One"},{"key":"929_CR35","doi-asserted-by":"crossref","unstructured":"Bonechi, C., Martini, S. & Rossi, C. Interaction study of bioactive molecules with fibrinogen and human platelets determined by 1H NMR relaxation experiments. Bioorg. Med. Chem. 17, 1630\u20131635  (2009).","DOI":"10.1016\/j.bmc.2008.12.063"},{"key":"929_CR36","doi-asserted-by":"crossref","unstructured":"Azpiazu, I. & Chapman, D. Spectroscopic studies of fibrinogen and its plasmin-derived fragment. Biochim. Biophys. Acta 1119 (3), 268\u2013274  (1992).","DOI":"10.1016\/0167-4838(92)90213-W"},{"key":"929_CR37","doi-asserted-by":"crossref","unstructured":"Barbucci, R., Lamponi, S. & Magnani, A. Fibrinogen conformation and platelet reactivity in relation to material\u2212 blood interaction: effect of stress hormones. Biomacromolecules 4, 1506\u20131513  (2003).","DOI":"10.1021\/bm0340366"},{"key":"929_CR38","doi-asserted-by":"crossref","unstructured":"Ahmad, E., Rabbani, G., Zaidi, N., Ahmad, B. & Khan, R. H. Pollutant-induced modulation in conformation and \u03b2-lactamase activity of human serum albumin. PLoS One 7(6), e38372  (2012).","DOI":"10.1371\/journal.pone.0038372"},{"key":"929_CR39","doi-asserted-by":"crossref","unstructured":"Madrazo, J. et al. Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-\u00c5 resolution. Proc. Natl. Acad. Sci. 98(21), 11967\u201311972  (2001).","DOI":"10.1073\/pnas.211439798"},{"issue":"18","key":"929_CR40","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1021\/bi802205g","volume":"48","author":"JM Kollman","year":"2009","unstructured":"Kollman, J. M., Pandi, L., Sawaya, M. R., Riley, M. & Doolittle, R. F. Crystal structure of human fibrinogen. Biochemistry 48 (18), 3877\u20133886 (2009).","journal-title":"Biochemistry"},{"issue":"11","key":"929_CR41","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/bi0525369","volume":"45","author":"I Pechik","year":"2006","unstructured":"Pechik, I., Yakovlev, S., Mosesson, M. W., Gilliland, G. L. & Medved, L. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry 45 (11), 3588\u20133597 (2006).","journal-title":"Biochemistry"},{"key":"929_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.1983.tb23257.x","volume":"408","author":"JW Weisel","year":"1983","unstructured":"Weisel, J. W., Phillips, G. N. Jr & Cohen, C. The structure of fibrinogen and fibrin: II. Architecture of the fibrin clot. Ann. N. Y. Acad. Sci. 408, 367\u2013379 (1983).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"929_CR43","doi-asserted-by":"publisher","first-page":"e61820","DOI":"10.1590\/fst.61820","volume":"42","author":"F Syahbanu","year":"2021","unstructured":"Syahbanu, F., Giriwono, P. E., Tjandrawinata, R. R. & Suhartono, M. T. Molecular Docking of subtilisin K2, a fibrin-degrading enzyme from Indonesian Moromi, with its substrates. Food Sci. Technol. 42, e61820 (2021).","journal-title":"Food Sci. Technol."},{"key":"929_CR44","doi-asserted-by":"publisher","first-page":"132963","DOI":"10.1016\/j.molstruc.2022.132963","volume":"1262","author":"X Li","year":"2022","unstructured":"Li, X., Duan, H., Song, Z. & Xu, R. Comparative study on the interaction between fibrinogen and flavonoids. J. Mol. Struct. 1262, 132963 (2022).","journal-title":"J. Mol. Struct."},{"issue":"22","key":"929_CR45","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.3390\/molecules25225425","volume":"25","author":"M Gonz\u00e1lez-Durruthy","year":"2020","unstructured":"Gonz\u00e1lez-Durruthy, M. et al. Targeting beta-blocker drug\u2013drug interactions with fibrinogen blood plasma protein: a computational and experimental study. Molecules 25 (22), 5425 (2020).","journal-title":"Molecules"},{"key":"929_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbrc.2021.07.076","volume":"572","author":"M Aalikhani","year":"2021","unstructured":"Aalikhani, M., Alikhani, M., Shamsabadi, F., Oladnabi, M. & Bazi, Z. In Silico drug repurposing for the treatment of heart diseases using gene expression data and molecular Docking techniques. Biochem. Biophys. Res. Commun. 572, 138\u2013144 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"929_CR47","doi-asserted-by":"publisher","first-page":"120370","DOI":"10.1016\/j.molliq.2022.120370","volume":"366","author":"M Gonz\u00e1lez-Durruthy","year":"2022","unstructured":"Gonz\u00e1lez-Durruthy, M., Rial, R., Liu, Z. & Ruso, J. M. Lysozyme allosteric interactions with \u03b2-blocker drugs. J. Mol. Liq. 366, 120370 (2022).","journal-title":"J. Mol. Liq."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00929-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:57:06Z","timestamp":1757476626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00929-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00929-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research\u2019s basic investigations did not involve the use of humans or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}],"article-number":"31524"}}